Ingestible sensors is an innovative technologically advanced product
of digital medical industry. Ingestible Sensors are pills that have
the ability to detect various bodily functions and activities,
medication check, heart rate and blood pressure. It has three
components sensors, data recorder, and software. These ingestible
sensors help patients receive real-time information and address the
unaware issues which are sometimes not answered by doctors. The
ingestible sensor works as soon as the sensor enabled pill is
consumed. This pill sends signals to the patch, which helps to detect
the duration in which the pill was consumed. As the data is recorded,
the information is being displayed with the help of linked discover
application that can be downloaded on a mobile device. With the help
of this application patients can analyze the data and work
accordingly, this helps them to decide if there is any need to visit
a healthcare provider, taking medication on time and others. The
ingestible sensors market is driven by increasing prevalence of
chronic conditions and advancement in technology.
The
Centers for Disease and Control of Infection states that about 36.5%
of the overall adults in the U.S. suffer from obesity and related
conditions. Obesity has led to a high prevalence of heart disease,
diabetes, certain types of cancer, and stroke amongst other diseases.
This reason alone has provided the overall ingestible sensors market
in a terrific momentum with North America in the lead. These sensors
gather real-time information and offer an effective solution for the
issues that most patients or doctors cannot identify. Today, these
sensors are linked to the smartphones and thus help the patients to
analyze the data and improve disease management.
Analysts
predict that changing lifestyles that tilting towards sedentary
patterns and the growing number chronic condition cases are
anticipated play a crucial role in the growth of the global
ingestible sensors market. The rising disposable incomes, improving
healthcare infrastructure in developing countries, and growing
awareness about options for treating a disease are all expected to a
significant contribution to the global ingestible sensors market in
the coming few years. The report indicates that Asia Pacific will
also emerge as a leading segment as the region boasts a significant
pool of geriatrics and exhibits a large number of unmet medical
needs. Furthermore, the entry of new players will also offer end
users such as research institutes, healthcare providers,
pharmaceutical companies, and sports and physical fitness
institutions myriad options at competitive pricing.
Obtain the Futuristic Insights for Ingestible Sensors at: http://bit.ly/2gnNElj
North
America followed by Europe is dominating the Ingestible sensors
market as a high incidence of gastroparesis cases, and favorable
reimbursement options provided by governments and insurance companies
which have provided the platform for these products. In Asia Pacific
region the Ingestible sensors market is expected to deliver
significant growth due to the high pool of geriatric population in
this region and growing economy which is expected to further fuel
market demand. Moreover, the Ingestible sensors market is expected to
become highly competitive due to the potential entrants in the market
by the end of forecast period.
Some
of the leading players operating in the global ingestible sensors
market are CapsoVision, Inc., HQ, Inc., Given Imaging, Ltd., Proteus
Digital Health, Inc., Olympus Corporation, and Medimetrics
Personalized Drug Delivery B.V. The research report provides a
complete analysis of the competitive landscape present in the global
market. Furthermore, it also offers an assessment of the research and
development activities of these companies, their business and
marketing strategies, and expansion plans for the coming few years.
Additionally, the document also provides a compilation of comments
and recommendations from expert market players for the existing and
new players to help them formulate their strategies.
No comments:
Post a Comment